EX-99.77O RULE 10F-3 4 dpt10f3.htm BIOMED
SCHEDULE B
RULE 10f-3 REPORT FORM
Record of Securities Purchased
Under the Delaware Investments Family of Funds' Rule 10f-3 Procedures
(Sub-Adviser Name)

1.	Name of Fund: Delaware Pooled Trust - The Real Estate Investment Trust Portfolio II (NB)

2.	Name of Issuer: Biomed Realty Trust Inc (BMR, 09063H107)

3.	Underwriter from whom purchased: Wachovia Securities (Wells Fargo Bank)

4.	Affiliated Underwriter managing or participating in underwriting syndicate: Raymond James,
Morgan Stanley, UBS Financial, Deutsche Bank, McDonald Keybank, Stiefel, Robert Baird,
RBC Capital, Royal Bank Scotland, BMO Capital, Macquarie Securities

5.	Aggregate principal amount of purchase by all investment companies advised by the
   Adviser: Total Bought by Delaware Investments 75,000@17.500 = $1,312,500.00

6.	Aggregate principal amount of offering: 15,000,000 X 17.50 = $262,500,000.00

7.	Purchase price (net of fees and expenses): $17.5000 USD

8.	Offering price at close of first day on which any sales were made:

9.	Date of Purchase: September 23, 2010

10.	Date offering commenced: September 23, 2010

11.	Commission, spread or profit: ______ %  $0.42/share

12.	Have the following conditions been satisfied?	Yes	No

a.   The securities are:
part of an issue registered under the Securities Act of 1933 which
is being offered to the public;
X
__
part of an issue of Government Securities;
__
X
Eligible Municipal Securities;
__
X
sold in an Eligible Foreign Offering; OR
__
X
sold in an Eligible Rule 144A Offering?
(See Rule 10f-3 Procedures for definitions of defined terms used
herein.)
__
__

b.   (1)The securities were purchased prior to the end of the first day on
which any sales were made, at a price that is not more than the price
paid by each other purchaser of securities in that offering or in any
concurrent offering of the securities (except, in the case of an Eligible
Foreign Offering, for any rights to purchase that are required by law to
be granted to existing security holders of the issuer); OR

X
__
     (2) If the securities to be purchased were offered for subscription upon
exercise of rights, such securities were purchased on or before the
fourth day preceding the day on which the rights offering terminates?

X
__
c.   The underwriting was a firm commitment underwriting?

X
__
d.   The commission, spread or profit was reasonable and fair in relation to
that being received by others for underwriting similar securities during
the same period?

X
__
e.   The issuer of the securities, except for Eligible Municipal Securities,
and its predecessors has been in continuous operation for not less than
three years?

N/A
__
f.   (1) The amount of the securities, other than those sold in an Eligible
Rule 144A Offering (see below), purchased by all of the investments
companies advised by the Adviser and any purchases by another
account with respect to which the Adviser has investment discretion if
the Adviser exercised such discretion with respect to the purchase, did
not exceed 25% of the principal amount of the offering; OR

X
__
      (2) If the securities purchased were sold in an Eligible Rule 144A
Offering, the amount of such securities purchased by all of the
investment companies advised by the Adviser and any purchases by
another account with respect to which the Adviser has investment
discretion if the Adviser exercised such discretion with respect to the
purchase, did not exceed 25% of the total of:



      (i) The principal amount of the offering of such class sold by
underwriters or members of the selling syndicate to qualified
institutional buyers, as defined in Rule 144A(a)(1), plus



      (ii) The principal amount of the offering of such class in any concurrent
public offering?

N/A
__
g.   (1) No affiliated underwriter of the Purchasing Fund was a direct or
indirect participant in or beneficiary of the sale; OR

X
__
     (2) With respect to the purchase of Eligible Municipal Securities, such
purchase was not designated as a group sale or otherwise allocated to
the account of an affiliated underwriter?

N/A
__
h.   Information has or will be timely supplied to an appropriate officer of
the Fund for inclusion on SEC Form N-SAR and quarterly reports to
the Funds' Board of Directors?

X
__

All purchases described in this report were executed in compliance with Rule 10f-3 and the Rule
10f-3 procedures adopted by the Board of Directors of the Delaware Investments Family of
Funds.

I have submitted these answers and completed this form based on all available information.

Name: /s/ Babak Zenouzi

Title: Senior Portfolio Manager

Date: September 27, 2010
WS: MFG_Philadelphia: 843758: v1
WS: MFG_Philadelphia: 843758: v1